Editorial
doi: 10.1056/NEJM199610103351509.
Therapy for human immunodeficiency virus infection -- what have we learned?
- PMID: 8813046
- DOI: 10.1056/NEJM199610103351509
Item in Clipboard
Editorial
Therapy for human immunodeficiency virus infection -- what have we learned?
N Engl J Med.
.
No abstract available
Comment in
-
Viral load and combination therapy for human immunodeficiency virus.N Engl J Med. 1997 Mar 27;336(13):958-9; author reply 960. doi: 10.1056/NEJM199703273361314. N Engl J Med. 1997. PMID: 9072697 No abstract available.
-
Viral load and combination therapy for human immunodeficiency virus.N Engl J Med. 1997 Mar 27;336(13):959-60; author reply 960. N Engl J Med. 1997. PMID: 9072698 No abstract available.
Comment on
-
A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team.N Engl J Med. 1996 Oct 10;335(15):1081-90. doi: 10.1056/NEJM199610103351501. N Engl J Med. 1996. PMID: 8813038 Clinical Trial.
-
The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.N Engl J Med. 1996 Oct 10;335(15):1091-8. doi: 10.1056/NEJM199610103351502. N Engl J Med. 1996. PMID: 8813039 Clinical Trial.
-
Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinical Research on AIDS.N Engl J Med. 1996 Oct 10;335(15):1099-106. doi: 10.1056/NEJM199610103351503. N Engl J Med. 1996. PMID: 8813040 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
